Title: Impact of the recommendations of the United Nations Secretary-General’s High-Level Panel on Access to Medicines: Discussion in the context of the 2030 Agenda for Sustainable Development
Date: Wednesday, 24 May 2017, 18:00-19:30
Venue: Room 7, Palais des Nations, Geneva, Switzerland
Organizers: The South Centre, Morocco, Bolivia, India, Uganda, Venezuela, UNSG HLP A2M, PPD
Title: Responding to the Challenge of Antimicrobial Resistance
Perspectives of Civil Society, Intergovernmental Organisations and Developing Countries
Date: 22 May 2017, 17:45-18:45
Venue: Palais des Nations (Salle IX)
Organizers: The South Centre, MSF Access Campaign, DNDi, hai, Medicus Mundi International Network, ReAct
Highlights of the WHO Executive Board: 140th Session
The World Health Assembly (WHA), the highest body of the World Health Organization, will be meeting from 22-31 May 2017.
Earlier in January, the Executive Board of the WHO met and discussed on various strategic issues that will be carried forward to the WHA.
In this light, the South Centre has prepared a timely summary report in the form of a policy brief of the discussions that took place at the EB, to assist delegates and other stakeholders in their preparation for the discussions in the WHA.
Title: Briefing for Developing Countries on Global Trends and Linkages to Geneva Multilateral
Processes
Date: Monday, 13 February 2017, 9:30-13:00
Venue: Room XXIV, Palais des Nations
Organizer: The South Centre
Growing Coalition to Intensify Efforts to Address Global Antimicrobial Resistance
The South Centre supports increased global and national level advocacy for policy change and action to prevent the post-antibiotic era from becoming a bleak reality. This effort is being strengthened with the recent addition of five leading environmental and public health organizations to the Antibiotic Resistance Coalition (ARC). The ARC is an independent coalition of members from six continents working in health, agriculture, consumer, and development sectors. (more…)
A resolution by the World Health Assembly: Will there finally be a cure for diseases that affect the poor?
By Carlos Correa
On 26 May 2012 the World Health Assembly adopted a resolution that could mark the first step toward a change in the current pharmaceutical research model. The members of the World Health Organization (WHO) decided to undertake an in-depth examination, at the governmental level, of a report produced in April 2012 by an international group of experts that recommended the adoption of a binding convention on research and development (R&D) that, if approved and implemented, could generate the medicines needed, particularly in developing countries, to address communicable and non-communicable diseases.
